nLc4Cer (d18:1/16:0) is a glycolipid subtype that can be used as a useful glycolipid standard in the research of the pathogenesis of inflammatory diseases.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.